+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Dystonia - Pipeline Insight, 2025 - Product Thumbnail Image

Dystonia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Plasminogen Activators - Pipeline Insight, 2025 - Product Thumbnail Image

Plasminogen Activators - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Insulin Like Growth Factor 1 (IGF-1) Activators - Pipeline Insight, 2025 - Product Thumbnail Image

Insulin Like Growth Factor 1 (IGF-1) Activators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Von Willebrand's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Von Willebrand's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Viral Conjunctivitis - Pipeline Insight, 2025 - Product Thumbnail Image

Viral Conjunctivitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Seizures - Pipeline Insight, 2025 - Product Thumbnail Image

Seizures - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Insight, 2025 - Product Thumbnail Image

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Secondary Hyperparathyroidism - Pipeline Insight, 2025 - Product Thumbnail Image

Secondary Hyperparathyroidism - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Retinal Vein Occlusion - Pipeline Insight, 2025 - Product Thumbnail Image

Retinal Vein Occlusion - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Postherpetic Neuralgia - Pipeline Insight, 2025 - Product Thumbnail Image

Postherpetic Neuralgia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 65 Pages
  • Global
From
Portal Hypertension - Pipeline Insight, 2025 - Product Thumbnail Image

Portal Hypertension - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Porphyria - Pipeline Insight, 2025 - Product Thumbnail Image

Porphyria - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 65 Pages
  • Global
From
Pompe Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Pompe Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Polymyositis - Pipeline Insight, 2025 - Product Thumbnail Image

Polymyositis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Polycythemia - Pipeline Insight, 2025 - Product Thumbnail Image

Polycythemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 65 Pages
  • Global
From
Myasthenia Gravis- Pipeline Insight, 2025 - Product Thumbnail Image

Myasthenia Gravis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Helicobacter Pylori Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Helicobacter Pylori Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Exocrine Pancreatic Insufficiency - Pipeline Insight, 2025 - Product Thumbnail Image

Exocrine Pancreatic Insufficiency - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Essential Thrombocythemia - Pipeline Insight, 2025 - Product Thumbnail Image

Essential Thrombocythemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more